Table 2. Comparison of Good and Mild responders.
Variables | Good responders | Mild responders | p-value |
---|---|---|---|
Age (years) | 51.6 ± 11.2 | 46.8 ± 8.9 | n.s. |
Duration of illness (years) | 16.6 ± 5.7 | 13.5 ± 9.7 | n.s. |
Global Impression of change (pts) | 2.7 ± 0.5 | 1.8 ± 0.6 | < 0.0005 |
Duration of B12 injections (years) | 8.1 ± 6.4 | 2.2 ± 2.3 | < 0.0005 |
Interval days between B12 inj. | 3.8 ± 1.9 | 5.8 ± 1.7 | < 0.03 |
Folic acid mg/day | 6.7 ± 6.6 | 1.9 ± 2.0 | < 0.003 |
Use of high-concentrated B12 | 14/15 = 93% | 13/23 = 57% | < 0.03 |
MTHFR compound heterozygote | 1/15 = 7% | 8/23 = 35% | n.s. (< 0.07) |
Daily use of Thyroid hormone | 7/15 = 47% | 2/23 = 9% | < 0.02 |
Daily use of prescribed analgesic | 0/15 = 0% | 16/23 = 70% | < 0.0005 |
Fibromyalgia as part of ME | 3/15 = 20% | 12/23 = 52% | n.s. (< 0.09) |
Mean ± SD or frequency/percentage for a number of variables in Good (n = 15) or Mild responders (n = 23). P-value is calculated by Student’s t-test, or by Fischer’s exact two-tailed test in the categorical data. (n.s. = no significance)